CIK 0001581280
- Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462058888
- Phone
- +1 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $93,935,246
- in 37 filings, $73.3M under 10b5-1 plans
Net −$93,935,246. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Leproust Emily M. −$77.3M Chief Executive Officer sold 44% of stake
- Finn Patrick John −$7.4M President and COO sold 18% of stake
- Laponis Adam −$2.8M Chief Financial Officer sold 14% of stake
- Green Paula −$2.8M SVP of Human Resources sold 24% of stake
- Cho Dennis −$2.8M Reporting owner sold 19% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-06 | Green Paula SVP of Human Resources | Sale | −860 | $52.70 | $45K | 133,715 |
| 2024-12-06 | Leproust Emily M. Chief Executive Officer | Sale | −2,216 | $52.70 | $117K | 674,718 |
| 2024-12-06 | WERNER ROBERT F. Chief Accounting Officer | Sale | −226 | $52.70 | $12K | 53,043 |
| 2024-12-05 | CHESS ROBERT Director | Exercise or conversion 10b5-1 | +3,504 | $8.82 | $31K | 25,145 |
| 2024-12-05 | CHESS ROBERT Director | Sale 10b5-1 | −2,795 | $51.70 | $145K | 22,350 |
| 2024-12-05 | CHESS ROBERT Director | Sale 10b5-1 | −709 | $52.45 | $37K | 21,641 |
| 2024-12-05 | CHESS ROBERT Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,504 | 0 | ||
| 2024-12-04 | Leproust Emily M. Chief Executive Officer | Grant or award | +95,350 | 676,934 | ||
| 2024-12-04 | Finn Patrick John President and COO | Grant or award | +53,634 | 274,695 | ||
| 2024-12-04 | Laponis Adam Chief Financial Officer | Grant or award | +26,745 | 115,982 | ||
| 2024-12-04 | Green Paula SVP of Human Resources | Grant or award | +20,428 | 134,575 | ||
| 2024-12-04 | Cho Dennis | Grant or award | +22,824 | 113,987 | ||
| 2024-12-04 | WERNER ROBERT F. Chief Accounting Officer | Grant or award | +8,438 | 53,269 | ||
| 2024-11-25 | WERNER ROBERT F. Chief Accounting Officer | Sale | −789 | $44.20 | $35K | 44,831 |
| 2024-11-11 | Cho Dennis | Sale | −1,507 | $48.00 | $72K | 91,163 |
| 2024-11-11 | Finn Patrick John President and COO | Sale | −10,340 | $48.00 | $496K | 221,061 |
| 2024-11-11 | Green Paula SVP of Human Resources | Sale | −1,347 | $48.00 | $65K | 114,147 |
| 2024-11-11 | Leproust Emily M. Chief Executive Officer | Sale | −7,968 | $48.00 | $382K | 581,584 |
| 2024-11-11 | CHESS ROBERT Director | Exercise or conversion 10b5-1 | +3,600 | $8.82 | $32K | 25,241 |
| 2024-11-11 | CHESS ROBERT Director | Sale 10b5-1 | −2,324 | $46.99 | $109K | 22,917 |
Page 20 of 22 · 435 trades